ASX:MTM
ASX:MTMMetals and Mining

Metallium (ASX:MTM) Moves to Advance Rare Earth Supply Independence With Ucore Collaboration

On September 16, 2025, Metallium Ltd. announced a binding Technology Collaboration Agreement with Ucore Rare Metals Inc. to integrate their Flash Joule Heating upgrade platform with Ucore's RapidSX™ rare earth separation technology, advancing a collaborative feedstock-to-oxide refining process in North America. This partnership directly targets critical gaps in U.S. rare earth supply chains and leverages federal support aimed at achieving independent, scalable refining capabilities separate...
ASX:PDN
ASX:PDNOil and Gas

How Paladin Energy’s (ASX:PDN) A$231 Million Equity Raise Has Changed Its Investment Story

Paladin Energy recently completed a follow-on equity offering of A$231.39 million, issuing 31,915,288 ordinary shares at A$7.25 each, and announced a further A$20 million offering. This substantial capital raise highlights the company's efforts to secure funding, which could support project development or balance sheet objectives and may affect future investor sentiment and funding options. With this significant equity issuance, we'll examine how Paladin's capital strategy could influence...
ASX:NEC
ASX:NECMedia

Could Director Share Buys at Nine (ASX:NEC) Reveal Shifting Leadership Confidence?

In September 2025, Nine Entertainment Holdings disclosed that Director Mandy Pattinson acquired 20,000 additional shares on-market, raising her total to 70,000 shares. Pattinson's purchase represents a meaningful increase in director ownership, which can impact how stakeholders view leadership confidence and the company's outlook. Next, we'll consider how this director's share purchase may reinforce perceptions of executive confidence within Nine Entertainment's investment narrative. AI is...
ASX:AYA
ASX:AYAHealthcare Services

Artrya (ASX:AYA): Assessing Valuation After Recent AUD 80 Million Equity Raise

Artrya (ASX:AYA) has drawn fresh attention after announcing a completed AUD 75 million follow-on equity offering, swiftly followed by another AUD 5 million raise. Both capital injections, priced at AUD 2.05 per share, indicate the company’s intent to bolster its balance sheet, pursue growth opportunities, or fund ongoing projects. For investors tracking the healthcare space, sizeable fundraising like this can be a turning point. It may signal management’s confidence in future prospects or a...
ASX:FID
ASX:FIDCapital Markets

3 ASX Dividend Stocks With Up To 8% Yield

As the Australian market navigates a period of nervousness, aligning with its Asian counterparts and awaiting key decisions like the Fed rate cut, investors are keenly observing sector performances where utilities are leading while discretionary sectors lag. In this environment, dividend stocks can offer a measure of stability and income potential, making them an attractive option for those looking to balance risk with consistent returns amidst fluctuating market conditions.
ASX:PYC
ASX:PYCBiotechs

High Growth Tech Stocks in Australia for September 2025

The Australian market has shown signs of nervousness, aligning with its Asian counterparts as investors anticipate the upcoming Federal Reserve rate cut decision, while profit-taking activities have tempered recent gains. In this climate of cautious optimism and fluctuating sentiment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and resilience amidst broader economic uncertainties.